The Disease Risk Index predicts outcomes including relapse and survival in CD34-selected allogeneic HCT for acute leukemia and myelodysplastic syndrome Meeting Abstract


Authors: Cho, C.; Hilden, P.; Peled, J. U.; Avecilla, S. T.; Barba, P.; Barker, J. N.; Castro-Malaspina, H. R.; Giralt, S. A.; Jakubowski, A. A.; Koehne, G.; Meagher, R. C.; Maloy, M. A.; O'Reilly, R. J.; Papadopoulos, E. B.; Ponce, D. M.; van den Brink, M. R. M.; Young, J. W.; Perales, M. A.
Abstract Title: The Disease Risk Index predicts outcomes including relapse and survival in CD34-selected allogeneic HCT for acute leukemia and myelodysplastic syndrome
Meeting Title: 58th Annual Meeting of the American Society of Hematology (ASH)
Journal Title: Blood
Volume: 128
Issue: 22
Meeting Dates: 2016 Dec 3-6
Meeting Location: San Diego, CA
ISSN: 0006-4971
Publisher: American Society of Hematology  
Date Published: 2016-12-02
Language: English
ACCESSION: WOS:000394452507116
PROVIDER: wos
DOI: 10.1182/blood.V128.22.3498.3498
Notes: Meeting Abstract: 3498 -- Source: Wos
Altmetric
Citation Impact
MSK Authors
  1. Sergio Andres Giralt
    965 Giralt
  2. Doris Ponce
    234 Ponce
  3. Miguel-Angel Perales
    820 Perales
  4. Juliet N Barker
    333 Barker
  5. Guenther Koehne
    194 Koehne
  6. James W Young
    317 Young
  7. Richard O'Reilly
    735 O'Reilly
  8. Molly Anna Maloy
    267 Maloy
  9. Christina Cho
    131 Cho
  10. Richard Charles Meagher
    43 Meagher
  11. Patrick Dale Hilden
    107 Hilden
  12. Jonathan U Peled
    137 Peled